Kaplan-Meier Survival: RETHYMIC Clinical Program (Efficacy Analysis Set) and Natural History Population Kaplan-Meier Survival: RETHYMIC Clinical Program (Efficacy Analysis Set)...
NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics...
LOS ANGELES, Oct. 08, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that...
CAMBRIDGE, Mass. and NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
BURNABY, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced...
Immediate Release – October 8th, 2021 Louvain-la-Neuve, Belgium, October 8th, 2021 - In accordance with article 8:4 of the Royal...
Six Towers Completed with a value of $350,000VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP....
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD)Gantenerumab is the first and only anti-amyloid...
Improved rating demonstrates Clover’s ability to deliver high-quality healthcare to Medicare eligibles on a wide, open networkNASHVILLE, Tenn., Oct. 08,...
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered...